VIPoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{VIPoma}} | {{VIPoma}} | ||
{{CMG}}{{AE}}{{PSD}} | |||
==Overview==The most common risk factor in the development of VIPoma is positive family history of [[multiple endocrine neoplasia type 1]]. | |||
==Risk Factors== | |||
The most common risk factor in the development of VIPoma is positive family history of [[multiple endocrine neoplasia type 1]]. | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 14:55, 19 October 2015
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma risk factors On the Web |
|
American Roentgen Ray Society Images of VIPoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2] ==Overview==The most common risk factor in the development of VIPoma is positive family history of multiple endocrine neoplasia type 1.
Risk Factors
The most common risk factor in the development of VIPoma is positive family history of multiple endocrine neoplasia type 1.